• Until a treatment or vaccine for COVID-19 is finalized and able to be widely dispersed, uncertainty in the US is likely to remain prevalent, as is the impetus for further federal monetary and fiscal aid aimed at containing the pandemic’s economic damage.
  • The amount of money spent at the federal level to address the COVID-19 pandemic could result in a structural rethinking of non-discretionary spending, including Medicare and Medicaid. Advancements in telemedicine brought on by the pandemic could help address some system-wide inefficiencies.
  • Although lawmakers from both parties have considered altering Senate filibuster rules over recent decades, the results of the November 2020 election are not likely to change a sense of caution about changes, given that modifications could significantly limit the power of any minority party well into the future.
This material is provided for informational purposes only and should not be construed as investment advice.

There can be no assurance that developments will transpire as forecasted. Actual results may vary.

The views and opinions expressed may change based on market and other conditions.